Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galvokimig in Non-Cystic Fibrosis Bronchiectasis (ATMOS)
NCT07720375Phase 2Recruiting
- Sponsor
- UCB
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of galvokimig in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by UCB. Started Aug 2026; status: recruiting.
02
Drugs
galvokimig
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT07720375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720375.